MedPage Today on MSN
Patients Can Manage Their Own Warfarin Just Fine, Study Suggests
Clinic-free approach tests the waters in the U.S.
A study has developed a reliable way to measure whether seriously ill hospitalized patients receive medical care that aligns with their personal goals. The research, involving 109 seriously ill ...
Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety ...
New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery, and radiation for some forms of cancer. Nearly 80% of patients who suffered from a ...
Countries with stricter and better-targeted climate policies cut carbon emissions faster, according to a major new study by researchers in the UK and EU. The study draws on the most comprehensive ...
HeartBeam, Inc. (BEAT), (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that its groundbreaking ...
COPENHAGEN, DENMARK, March 18, 2026 - BioPorto A/S ("BioPorto” or "Company”) (CPH: BIOPOR) today announced positive clinical readout update of the preliminary analysis of its U.S. adult NGAL Cutoff ...
How small is "small?" Spider silk nanofibrils are just a few molecular layers thick, equivalent to approximately one ten-thousandth the diameter of a human hair. They're invisible to the naked eye and ...
n = number of patients included in each study group for HbA1c and body weight efficacy assessments Abbreviations: EOS: End of Study (week 16); Wk: week; BID: twice daily; CBD: cannabidiol; QD: once ...
Health and Me on MSN
Study Claims Obese Kids Who Successfully Lose Weight Are Less Prone To Serious Ailments Later in Life
While weight gain is not seen as an issue in kids, more and more studies are showing that it should be an issue. Usually ...
DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus ® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus ® Recent financings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results